Form 4: Cyanotech Chief Scientific Officer Converts Restricted Stock Units, Adjusts Holdings

Cyanotech's Chief Scientific Officer, Gerald R. Cysewski, converted restricted stock units into common stock and had shares withheld for tax obligations.

Summary

• Gerald R. Cysewski, Chief Scientific Officer of Cyanotech Corp (CYAN), reported changes in his beneficial ownership of common stock.
• On July 29, 2025, 1,577 restricted stock units (RSUs) vested and converted into 1,577 shares of common stock.
• Concurrently, 592 shares of common stock were withheld by the company at a price of $0.405 per share to satisfy payroll tax liabilities associated with the RSU vesting.
• Following these transactions, Mr. Cysewski directly holds 146,697 shares of common stock.
• An additional 250 shares of common stock are indirectly held by his spouse.
• Mr. Cysewski retains 34 restricted stock units that are scheduled to vest on April 6, 2026, contingent on his continued service with the company.

Sentiment

Score: 6

Explanation: The filing reflects a routine, pre-scheduled executive compensation event (RSU vesting) which is generally positive as it aligns executive interests with shareholders, though the tax withholding is a standard part of such transactions and not a negative surprise.

Positives

• The vesting of restricted stock units indicates the fulfillment of compensation agreements and continued commitment of a key executive.
• The conversion of RSUs into common stock increases the direct equity ownership of the Chief Scientific Officer, aligning his interests with shareholders.

Negatives

• A portion of the vested shares (592 shares) was withheld by the company to cover tax liabilities, reducing the net increase in the executive's direct holdings.

Future Outlook

The Chief Scientific Officer has 34 remaining restricted stock units that are scheduled to vest on April 6, 2026, subject to his continued service with the company.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, specifically the vesting of restricted stock units. Such transactions are common across industries as part of long-term incentive plans for executives.

Stakeholder Impact

• Shareholders: The increase in direct ownership by a key executive through RSU vesting can be viewed positively as it aligns management's interests with shareholder value.

Next Steps

• Vesting of 34 remaining restricted stock units on April 6, 2026, contingent on continued service.

Key Dates

Recommendation

This Form 4 details a routine vesting of restricted stock units and subsequent tax withholding, which is a common event for executive compensation and does not provide new fundamental information to alter an investment thesis. It is a standard disclosure and not indicative of significant operational or strategic changes.

Keywords

Cyanotech, CYAN, Form 4, Insider Trading, Restricted Stock Units, RSU, Stock Vesting, Executive Compensation, Gerald Cysewski, Chief Scientific Officer